The iconic rise of Viagra has long been a symbol of pharmaceutical success, yet its legacy within the broader market now triggers questions about potential yields . Generic versions are eroding market share, prompting concerns that betting on companies significantly dependent to Viagra's previous influence could be a problematic decision , especial